Delivery Order SPE2DB22D2206-SPE2DB24FHJ37
Award Date
5/22/24
Potential Completion Date
5/23/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,472.70 for the supply of 8 mg Ramelteon tablets. The ultimate completion date is May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.56 firm fixed-price delivery order covers the supply of Ramelteon 8 mg tablets for the DLA Troop Support Medical program. The contract has a period of performance through November 27, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,681.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET 30S, a prescription medication, with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, SPE2DB22D3401|SPE2DB24FT4XB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,148.04 delivery order is for the supply of RAMELTEON 8 MG TABLET 30S medication. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of 8 mg Ramelteon tablets, a medication used to treat insomnia. The contract has a ceiling value of $7,418.36 and is a firm fixed-price contract, with a period of performance ending on June 27, 2025. This contract is not set-aside and was competed openly. Amerisourcebergen Drug Corp is a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
The Defense Logistics Agency awarded a delivery order valued at $394.39 to Amerisourcebergen Drug Corporation for the supply of 4561543359 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 100 units of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania under a firm fixed price contract executed on July 19, 2023 for completion by July 20, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.38, is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...